US EditionNovo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy
- Novo Nordisk announced deals Tuesday allowing telehealth companies to sell branded Wegovy.
- The action follows the FDA stating Wegovy is not in shortage, limiting compounded drug use.
- The agreements distribute the drug through the NovoCare Pharmacy for cash-paying patients.
- Ro and LifeMD price Wegovy at $499 monthly; Hims sets its price at $599.
- These agreements may broaden access for patients paying cash and boosted partner companies' stock.
22 Articles
22 Articles
Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to stem sales of copies of its popular weight-loss drug and expand access to cash-paying patients.
Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy
Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would be partnering with Hims & Hers., LifeMD and Ro. to provide all five dose strengths of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499. All doses will be delivered with a once-weekly single-dose pen. Novo Nordisk's direct-to-consumer pha…
Hims & Hers partners with Novo Nordisk to sell Wegovy
Hims & Hers Health announced on Tuesday it will bundle Wegovy with the telehealth platform’s membership through a new collaboration with drugmaker Novo Nordisk.The bundle will offer Novo Nordisk’s popular weight-loss drug at all its dosage strengths paired with a Hims & Hers membership providing "access to 24/7 care, ongoing clinical support, and nutrition guidance," Hims & Hers said. "We’re excited to work with Novo Nordisk, a company known for…
Novo Nordisk announces plan to offer Wegovy via telehealth services
Telehealth providers will soon offer more affordable access to weight loss drug Wegovy, according to manufacturer Novo Nordisk.The drugmaker announced Tuesday it had reached an agreement with telehealth groups Hims & Hers, Ro and LifeMD to sell name-brand Wegovy at reduced prices, which will make the drug more accessible to those without health insurance coverage.Through the program, Wegovy will sell for $499 per month, plus the cost of monthly …
Coverage Details
Bias Distribution
- 83% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
